Cotinga Pharmaceuticals PER
¿Qué es el PER de Cotinga Pharmaceuticals?
El PER de Cotinga Pharmaceuticals, Inc. es N/A
¿Cuál es la definición de PER?
La relación precio/ganancias es la relación entre el precio de las acciones de una compañía y las ganancias por acción de la compañía calculadas en los últimos doce meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
PER de compañías en Sector Health Care en TSXV en comparadas con Cotinga Pharmaceuticals
¿Qué hace Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Empresas con per similar a Cotinga Pharmaceuticals
- InvoCare tiene PER de N/A
- Argen X SE tiene PER de N/A
- Indiabulls Ventures tiene PER de N/A
- Kokuyo Camlin tiene PER de N/A
- Hong Kong Television Network tiene PER de N/A
- Biocorp Production tiene PER de N/A
- Cotinga Pharmaceuticals tiene PER de N/A
- Tailam Tech Constr Hldg Ltd tiene PER de N/A
- MPC Münchmeyer Petersen Capital AG tiene PER de N/A
- MAG Silver tiene PER de N/A
- Hays plc tiene PER de N/A
- Two Shields Investments Plc tiene PER de N/A
- MAG Silver tiene PER de N/A